Survival after Pneumonectomy for Stage III Non-small Cell Lung Cancer
Objectives: Stage III non-small cell lung cancer (NSCLC) has a poor prognosis. Reports suggest that five-year survival after current treatment is between 14 to 24 percent. The purpose of this retrospective study was to investigate the morbidity and mortality of patients diagnosed with stage III NSCL...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Oman Medical Specialty Board
2014-01-01
|
Series: | Oman Medical Journal |
Subjects: | |
Online Access: | http://www.omjournal.org/fultext_PDF.aspx?DetailsID=488&type=fultext |